19 distributors signed, demonstrating strong interest and momentum for its molecular detection platform, which provides a foundation for rapid, accurate, point-of-need pathogen testing across Human In Vitro Diagnostics, Agricultural, and Bioindustrial markets
Alameda, Calif. – December 13, 2023 – Alveo Technologies, Inc., a leader in molecular sensing and diagnostics with its proprietary technology platform, today announced 19 new distributor partnerships across Europe, Africa, and the Middle East (EMEA). These new partnerships expand its global reach to support Alveo’s 2024 product launches and to fulfill demand for its current COVID-19 product already on the market.
The new distribution partnerships include:
Europe
• Biosan (Hungary)
• Farmas (North Macedonia, Albania, Kosovo)
• Hydrox (Lithuania, Latvia, Estonia)
• InterPharm (Montenegro)
• MD Solutions (Serbia)
• OK SERVIS Biopro (Czech Republic, Slovakia)
• Synmed Bulgaria Ltd (Bulgaria)
• Synmedom (Romania)
• Syntec Scientific Ltd (Ireland)
• Techtum Lab AB (Sweden)
Middle East
• Al Hayat Pharmaceutical (United Arab Emirates)
• Al Suwaidi (Qatar)
• Bioteck (Lebanon)
• Genetics Code (Jordan)
• Ideal Medical Company Limited (Saudi Arabia)
• Ultra Diagnostic (Egypt)
